Form EFFECT Inhibikase Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 16, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Richmond Ave Dealer Adds Atomic-Level Watch Checks in 2026
- Ethereum Price Prediction Points Higher as Pepeto Presale Hits $10.3 Million
- Ping An Ranks No. 26 on Forbes 2026 Global 2000 List, No. 2 Among Global Insurers
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
